PR Newswire BiotechOriginal article
WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Positive
AI Analysis
Summary
WallachBeth Capital announced the closing of bioAffinity Technologies' $4 million registered direct financing of common stock with a concurrent private placement priced at-the-market under Nasdaq rules.
Importance:3/10
Sentiment:
0.30
capital_raiseregistered_direct_offeringprivate_placementbioAffinity_Technologies
Related Companies
Read the original article
Published by PR Newswire Biotech on October 9, 2026 4:30 PM